This will allow us to determine the correlation of the in vitro results with the actual in vivo responses
The latest in vitro and in vivo research results show that oxaliplatin-based oxidative stress enhance the phosphorylation level of serine residues of NFS1, which protect CRC cells in an S293 phosphorylation-dependent manner during oxaliplatin treatment (Lin et al., 2022)
Its safe to say that modest weight loss begins pretty much immediately after starting tirzepatide (within a few weeks)
Vara-Prez M, Rossi M, Van den Haute C, Maes H, Sassano ML, Venkataramani V, et al
It is also worth noting that rapid weight loss associated with GLP-1 receptor agonist therapy is linked to an increased risk of gallstone formation and gallbladder disease (cholecystitis), a class effect recognised in the SmPCs for semaglutide and tirzepatide